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A B S T R A C T
Background: Smoking prevalence remains signiﬁcantly higher among individuals with mental health conditions
compared with the general population. Tobacco harm reduction (THR) in the form of replacing cigarettes for
electronic cigarettes (ECs) is an alternative approach which may prove useful for these smokers who ﬁnd it
diﬃcult to quit. Exploring how mental health professionals' (MHPs) perceive ECs, and how these inﬂuence
decision making regarding their use in clinical settings is essential to determine the feasibility of incorporating
ECs into the treatment pathway.
Methods: We conducted six focus groups between March and August 2017. A total of 39 MHPs were recruited
from mental healthcare services in England. Discussions were guided by a semi-structured guide, and responses
were recorded, transcribed and coded using thematic framework analysis.
Results: MHPs generally adopt a risk-averse approach when judging the safety and suitability of ECs. Risk-
aversion was inﬂuenced by perceived obscurity surrounding ECs and THR, as well as high exposure to adverse
and unreliable information regarding ECs, and perceived analogies between ECs and conventional cigarettes.
Some MHPs adopt a pragmatic approach when making decisions based on THR and EC use in daily practice by
considering the context of treatment and patient circumstances. However, this is often accompanied by a high
degree of caution and misconceptions which limits the potential beneﬁt this intervention could have in mental
healthcare settings.
Conclusion: Improved dissemination of national guidance and scientiﬁc literature regarding THR and ECs is
essential in mental healthcare to eliminate misconceptions and better inform MHPs evidence-based decision-
making practices.
1. Background
Tobacco control is a key government initiative within the United
Kingdom (UK) (Department of health, 2017). In England, smoking
prevalence in the general population has declined from 24% in 2007, to
14.9% in 2017 (NHS digital, 2018). However, smoking prevalence
among individuals with mental health conditions in England has re-
mained high; estimated at around 34.1% in 2014 (Richardson, McNeill,
& Brose, 2019). Consequently, smoking within this population con-
tributes to an average of 17 life years lost (Harker & Cheeseman, 2016).
Speciﬁcally, in the United States (US), research indicates that smokers
with severe psychological distress (SPD) lose 14.9 years of life relative
to never-smokers without SPD, and 9.6 years relative to non-smokers
with SPD (Tam, Warner, & Meza, 2016). In an attempt to reduce
smoking prevalence in disadvantaged populations such as those with
mental health conditions, the National Institute for Health and Care
Excellence (NICE) in the UK has issued guidance and recommendations
to adopt tobacco harm reduction (THR) as an alternative approach to
cessation for those who ﬁnd it diﬃcult to quit (NICE, 2013). THR is a
strategy in which smokers are able to substitute cigarettes for less
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harmful nicotine-containing products, thus essentially maintaining a
desired level of nicotine intake while minimising exposure to harmful
chemical components present in tobacco smoke (Royal College of
Physicians, 2016).
Smoking is a complex bio-psycho-social behaviour incorporating
biological dependency, habits, beliefs and identity (Hughes, 2002).
Although traditionally licensed harm reduction products such as nico-
tine replacement therapies (NRT) deliver nicotine to the user and thus
satisfy the biological dependency, these products fail to address the
behavioural and social aspects of smoking. Subsequently, these pro-
ducts may not be well suited for highly dependent smokers, such as
those with mental health conditions (Ratschen, 2014). In contrast,
electronic cigarettes (ECs) relieve nicotine cravings, while simulta-
neously replacing the behavioural and social aspects of smoking
(Farrimond, 2017; Wadsworth, Neale, McNeill, & Hitchman, 2016). ECs
are able to achieve this as they are non-combustible, non-tobacco
products, which typically allow the user to inhale a vaporous solution of
nicotine suspended in a humectant (typically propylene glycol and
glycerine), thus providing nicotine delivery via a hand-to-mouth
movement (McNeill et al., 2018). In the UK, these products have be-
come the most popular smoking cessation aid, with an estimated 3.2
million EC users in 2017 (Action on Smoking and Health, 2018). Fur-
thermore, as more evidence emerges supporting their use for harm re-
duction purposes, bodies such as Public Health England (PHE) and the
Royal College of Physicians (RCP) in the UK, as well as the National
Academy of Sciences in the US, have concluded that smokers who are
unable to quit should consider converting to vaping as a safer alter-
native to conventional cigarettes (McNeill et al., 2018; National
Academies of Sciences, 2018; Royal College of Physicians, 2016).
In the context of mental healthcare, ECs may be one solution to
reduce smoking in these settings by functioning as a safer source of
nicotine (Ratschen, 2014). Research from the US indicates that smokers
with mental health conditions are more likely to have tried an EC and
be a current EC user in comparison with smokers in the general po-
pulation (Cummins, Zhu, Tedeschi, Gamst, & Myers, 2014). What is
more, a small number of randomised controlled trials (RCTs) and pilot
studies from Italy (Caponnetto, Auditore, Russo, Cappello, & Polosa,
2013), Australia (O'Brien, Knight-West, Walker, Parag, & Bullen, 2015)
and the UK (Hajek et al., 2019; Hickling et al., 2018) have found that
ECs are eﬀective in supporting smoking cessation and harm reduction
among smokers with mental illnesses. As a result of this growing body
of evidence, the Science and Technology Committee in London, Eng-
land, have advised mental health trusts to allow EC use on their pre-
mises (Science and Technology Committee, 2018).
However, research has found that MHPs are often reluctant to
support their patients to address their smoking, due to widely held
misconceptions regarding the necessity and appropriateness of smoking
cessation interventions in mental healthcare (Sheals, Tombor, McNeill,
& Shahab, 2016). Speciﬁcally, MHPs hold intrinsic biases regarding
patients' abilities and motivation to quit, and believe quitting smoking
is too much for patients to take on (Sheals et al., 2016). Nevertheless, it
remains unclear as to whether MHPs would be willing to support ECs
and THR as an alternative approach to cessation. Research to date has
only explored the acceptability of ECs among general healthcare per-
sonnel, with ﬁndings showing a degree of support from some (Kandra,
Ranney, Lee, & Goldstein, 2014; Lazuras, Muzi, Grano, & Lucidi, 2016),
and lack of support from others (Hiscock et al., 2014; Van Gucht &
Baeyens, 2016). In any instance, misperceptions and concerns are
prominent among healthcare personnel (Marques Gomes, Nabhani-
Gebara, Kayyali, Buonocore, & Calabrese, 2016; Pippard & Shipley,
2017; Stepney, Aveyard, & Begh, 2019), though there is some research
to suggest that there is high demand among healthcare personnel to
know more about ECs in order to better inform decisions regarding
their use by patients (Stepney et al., 2019). However, no research exists
exploring this among those working speciﬁcally with smokers who have
mental health conditions. This is of particular interest given that
smokers with mental health conditions are likely to turn to their
healthcare providers for advice and information regarding these pro-
ducts.
In light of the NICE guidance regarding THR, as well as the re-
commendations from PHE and RCP regarding the use of ECs for smo-
kers with mental illnesses, the present study aims to qualitatively ex-
plore how MHPs perceive THR and ECs, and how these inﬂuence their
decisions regarding their use in clinical settings.
2. Methods
2.1. Sample and recruitment
To recruit a diverse participant group to resemble the multi-
disciplinary nature of mental healthcare teams, a stratiﬁed purposive
sampling method was adopted. The lead author (CS) achieved this by
using the NHS England website to search for appropriate mental health
services local to the author that treated a diverse range of mental health
conditions. CS contacted appropriate services via email, and those who
indicated interest and capacity to participate were forwarded further
information about the purpose of the study.
In total, 39 MHPs participated in the present study; 36 were re-
cruited from ﬁve services within one of the largest mental health trusts
in Europe, and 3 were recruited from one service within another mental
health trust in London (See Table 1 for a breakdown of participant and
service characteristics). Services specialised in treatment for a range of
mental health conditions, including common mental disorders (e.g.
anxiety and depression), mood disorders, psychosis and personality
Table 1
Participant and service characteristics.
Participant characteristics (n=39) Mean (SD)
Age (years) 37.4 (13.5)a
Years in current role 6.4 (7.8)a
Gender n (%)
Male 11 (28.2)
Female 28 (71.8)
Service type n (%)
Secondary care inpatient wards 1 (16.7)
Secondary care community services 3 (50)
Primary care community services 2 (33.3)
Participants in each service n (%)
Secondary care inpatient wards 4 (10.3)
Secondary care community services 15 (38.5)
Primary care community services 20 (51.3)
Professional discipline n (%)
Occupational Therapistb 1 (2.6)
Psychiatrist 4 (10.3)
Clinical Psychologistb 4 (10.3)
Trainee Clinical Psychologist 2 (5.1)
Health Psychologist 1 (2.6)
Assistant Psychologist 1 (2.6)
Psychological Wellbeing Practitioner (PWP) 8 (20.5)
Trainee PWP 2 (5.1)
IAPTS placement student 1 (2.6)
Cognitive Behavioural Therapy (SBT) Therapist 1 (2.6)
Nurseb 5 (12.9)
Student Nurse 1 (2.6)
Social worker 4 (10.3)
Forensic Mental Health Practitioner 1 (2.6)
Support worker 1 (2.6)
Administrator/assistant 2 (5.1)
Self-reported smoking status n (%)
Non-Smoker 18 (46.2)
Ex-Smoker 14 (35.9)
Occasional/social smoker 6 (15.4)
Smoker 1 (2.6)
a Age was not disclosed by 6 MHPs.
b Includes acting service leaders (one occupational therapist, one clinical
psychologist, and three nurses).
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disorders.
2.2. Data collection
A total of six focus groups (one for each participating service) were
conducted between March and August 2017, with each lasting 45–60
minutes. The decision to conduct focus groups over individual inter-
views was made following two pilot interviews and one pilot focus
group, where it was decided that focus groups allowed for more
broadening exploration and opportunity for MHPs to generate and
share ideas/concerns regarding ECs and harm reduction. The rationale
for conducting focus groups for each service individually was that
participants would be able to engage in honest and elaborative dis-
cussion regarding ECs and THR with known colleagues, thus theoreti-
cally increasing the real-life applicability of this study's ﬁndings by
providing insight into the decision-making processes of multi-
disciplinary teams.
The focus groups were facilitated by CS, with the assistance of ZA.
All focus groups began with everyone introducing themselves to the
group. CS and ZA explained the purpose of the focus group, which was
read from the topic guide (Appendix A). Participants were provided
with the opportunity to ask questions after the information sheet was
provided and read aloud by CS or ZA, and participants were asked to
provide written consent before the focus groups began. All focus groups
were conducted in an interview room on the hospital site where the
services were based.
The facilitators used a semi-structured interview guide to direct the
discussions and prompt MHPs when needed. This guide was informed
following a review of the literature and was reﬁned using an iterative
process following piloting in two interviews and one focus group before
the study began. The ﬁnal topic guide (Appendix A) covered numerous
topics relating to tobacco control interventions and mental health:
1. Experiences of providing patients with smoking cessation support
2. Attitudes/perceptions toward THR
3. Attitudes/perceptions toward ECs
4. Attitudes/compliance of smoke-free policy in mental healthcare
For the purpose of the aims of this research paper, the data obtained
from questions three and four (regarding THR and ECs) were included
in the analysis of this paper. Data regarding MHPs' experiences of
providing smoking cessation interventions and attitudes/compliance
toward the smoke-free policy are reported in another qualitative paper
by the same authors (Smith, McNeill, Kock, & Shahab, 2019).
2.3. Ethical considerations and review
Participants received an information sheet at the start of each focus
group. This information was read aloud by either CS or ZA at the start of
each focus group. Participants were advised orally of their rights and
were assured of anonymity before they provided written consent. The
project was reviewed and approved by the University College London
ethics committee (application reference 10093/001).
2.4. Data analysis
With participants' permission, focus groups were audio recorded
and transcribed verbatim by CS, and were checked for accuracy by ZA.
Transcripts were interpreted and analysed using thematic analysis with
the framework method (Gale, Heath, Cameron, Rashid, & Redwood,
2013). This approach was chosen as framework analysis consists of
clearly deﬁned steps to follow and produces highly structured outputs
of summarised data. Data was managed using Nvivo (version 11) soft-
ware (Bazerley & Jackson, 2013) where authors (CS, LK and ZA) re-
corded initial descriptive themes. These authors independently devel-
oped over-arching themes and sub-themes, before reviewing each
other's draft themes and developing an agreed interpretation with the
input from fellow authors (AM and LS). CS charted the data into a
framework matrix, which involved summarizing the data for each
theme and case. Finally, a developed interpretive framework was pro-
duced by CS, and the remaining authors reviewed and agreed on the
ﬁnal framework.
3. Results
3.1. Theme 1: MHPs adopt a risk-averse approach when forming
perceptions and judgements regarding ECs safety and suitability
3.1.1. Sub-theme 1: perceived obscurity surrounding THR and ECs facilitate
misconceptions among MHPs
MHPs generally indicated a lack of awareness and knowledge of ECs
and THR. MHPs that had more knowledge about ECs, and the impact of
tobacco use on the mental health population, supported the use of ECs
in mental healthcare. However, many MHPs were unaware of the lit-
erature available on ECs. Uncertainty regarding the contents of ECs led
some MHPs to be cautious in their judgements by questioning whether
ECs are indeed a ‘safer’ alternative to smoking:
“It's diﬃcult to know as well how bad e-cigarettes are. I don't think
there is much research or general information about what are the
dangers, because they are a relatively new thing. So I guess having a
safe alternative; what does that actually mean? What is a safe al-
ternative? Are e-cigarettes a safe alternative?”
(Robbie, Community Setting, PWP, Non-Smoker)
In many cases, MHPs indicated their personal preferences for tra-
ditional NRT over ECs, in spite of recognising patients are generally not
interested in these products. However, this was often in the context of
cessation. Many MHPs were cautious to recommend ECs over NRT, as
ECs were perceived less as an intervention to smoking and more as a
potential lifestyle:
“I think with NRT there is that expectation that you are going to
reduce down, so it's clearer. But with vaping, maybe not so much,
and the paraphernalia around it, there is more potential for it to be a
lifestyle rather than a stepping stone towards complete cessation.”
(Margaret, Community Setting, Clinical Psychologist, Non-
Smoker)
This uncertainty surrounding the beneﬁts of THR and ECs often
perpetuated MHPs beliefs that ECs are products which prolong nicotine
addiction, rather than support patients to overcome an addiction. This
continued use of nicotine was perceived by many to be problematic,
which impaired MHPs ability to recognise the beneﬁt of ECs, and in
some cases NRT use, over combustible tobacco use:
“There is a plastic thing, a small one. I don't think I've ever seen
someone suck on anything as hard on that than the patients on the
ward when they were given that instead of access to cigarettes. It
almost seemed their nicotine intake was more than if they just had
the odd fag during the day because they were constantly 24 hours a
day you would see them, then they would go and get a reﬁll. Really
sucking really deeply… I don't know what it does or what's in it, but
it just struck me… I couldn't really see what the point of it was other
than stopping them for actually inhaling smoke.”
(Nigel, Community Setting, Clinical Psychologist, Ex-Smoker)
[…]
“The more it goes on the more upset I am about prescribing all these
extras because sometimes people use more nicotine than if they
were allowed to smoke every two hours.”
(Kelly, Community Setting, Psychiatrist, Ex-Smoker)
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3.1.2. Sub-theme 2: increased engagement with unreliable information
sources over trust resources perpetuate misconceptions among MHPs
The majority of MHPs were unaware of their trust's smoke-free
policy with regard to EC use, although many MHPs spoke about com-
pleting an annual online smoking cessation training module which
forms part of their mandatory professional development. However, only
a minority of MHPs recalled content regarding EC use, and only one
MHP indicated that they had read scientiﬁc literature supporting EC use
in comparison with cigarettes:
“I think there has been recent literature published that suggests the
harms from e-cigarettes in their current commercialised state are
less than the harms from cigarettes.”
(Sharon, Community Service, Psychiatrist, Ex-Smoker)
In contrast, the majority of MHPs were unable to recall EC content
covered on the training module which they had completed in the past
year, and in one case, the day before the focus group. Yet, many re-
called extreme cases of where they had heard or read ECs to be dan-
gerous or destabilising to wider tobacco control policy:
“I can't remember if ECs are covered in the e-learning… I can't re-
member if I read or heard it, but it was over the weekend, that
young people are taking up vaping rather than smoking, which that's
not what its meant to be… its meant to be an aid to stopping, isn't
it.”
(Hannah, Community Service, Nurse & Team Leader, Social
Smoker)
[…]
“I read something in the paper that the percentage of harm they are
doing compared to cigarettes is not a lot of percentage diﬀerence.”
(Charlotte, Inpatient Service, Admin and ward assistant, Non-
Smoker)
[…]
“When I did my e-learning yesterday they had all these awful che-
micals in a cigarette; arsenic and you mentioned tar, and toxins
really that are in the cigarette. So is that not in the e-cigarette?”
(Debbie, Inpatient Service, Nurse and Manager, Ex-Smoker)
In rare instances, this was taken further by some MHPs who stated
that any nicotine use poses threat to users' health:
“Well look at the spray, do you remember the spray? I swear they
said it was causing tongue cancer or throat cancer. So I think if you
want to stop smoking you should just stop altogether… I don't think
NHS should be prescribing nicotine for people at all.”
(Mandy, Community Service, Social Worker, Ex-Smoker)
3.1.3. Sub-theme 3: analogies between ECs and conventional cigarettes
triggers suspicion among MHPs when making judgements regarding THR and
ECs
Much criticism directed toward ECs appeared to be somewhat
driven by the perceived similarities between ECs and cigarettes; in-
cluding visual stimuli and behavioural actions produced during the use
of both products. This appeared to lead many MHPs to mistakenly
consider ECs to be a “type” of conventional cigarette, whereby the same
guidelines and terminology would apply to these users. These MHPs
therefore did not see the beneﬁt of substituting a cigarette for an EC:
“I think sometimes if you want a cigarette you kind of want the real
thing. I don't know how helpful ECs would be because it would still
be the same rules that you would have to leave and smoke, you
couldn't smoke on the wards, and with e-cigarettes it's the behaviour
you have to look at.”
(Charlie, Community Setting, Mental Health Practitioner,
Social Smoker)
Even among MHPs who had used ECs and thus supported their use
for THR, the perceived similarities shared between smoking and vaping
inﬂuenced the language which was used when discussing past experi-
ences of using these products. One occasional smoker who considered
himself an “ex-vaper” believed ECs to be better than NRT in the sense
that ECs provide a similar experience to using cigarettes. However, this
MHP explained how he perceived EC users to remain classiﬁed as
smokers, which was the consensus shared by many MHPs:
“If you just want to do harm reduction and you don't want to really
stop smoking then I think its ﬁne to use an electronic cigarette be-
cause your lungs deﬁnitely feel better on an e-cigarette… I couldn't
do research in it, but I think it just sounds logical that it's safer than
smoking cigarettes. The problem is then you're stuck on that so
what's the point? You're still an addict to nicotine… you're not
classiﬁed as a non-smoker”.
(Martin, Community Setting, Psychiatrist, Social Smoker)
Many MHPs spoke about ECs as being the new craze in the smoking
world; referencing the increase in number of vape shops on the high-
streets over recent years. Discussions regarding the perceived glamor-
isation of ECs, along with product advancement and diversity, led one
MHP to express how he felt this to be a marketing strategy employed by
the tobacco industry to maximise proﬁt that was being threatened due
to the decrease in tobacco smoking prevalence in the general popula-
tion:
“Well cynically I feel that the tobacco industry who own all this as I
understand as well, so to think people aren't going to smoke cigar-
ettes that they are making sure that they corner the market to make
e-cigarettes as elaborate as they can to make sure that people spend
a lot of money on them”
(Jack, Community Setting, Social Worker, Ex-Smoker)
The perceived similarity between cigarettes and ECs led many MHPs
to predict that ECs would be exposed in the future as being harmful
products; replicating the timeline of events with regard to cigarettes
which were once endorsed by medical professionals, but were later
exposed as lethal products:
“I think ideally if someone wants to stop smoking then they should
stop smoking altogether. I think replacing it for lesser evil… in terms
of harm, in ﬁve or ten years' time we might be given new in-
formation that it causes physical health problems as well.”
(Jenny, Community Setting, Nurse, Social Smoker)
3.2. Theme 2: MHPs consider patient circumstances when making
judgements regarding EC use for THR purposes in clinical practice
3.2.1. Sub-theme 1: treatment context
Judgements regarding the suitability of using ECs for THR within a
clinical setting were sometimes dependent on the treatment context and
patients' individual circumstances. For instance, one MHPs expressed
how decisions regarding whether or not to allow patients' to use ECs, or
even conventional cigarettes, depended upon the patients' stage of
treatment. This was spoken in the context of working with patients who
have a history of substance abuse:
“I've seen people really suﬀer and struggle because they are not just
doing the patches, they are doing the chewing gum, and they are
doing everything! And they are hiding it, and it becomes a new… it's
almost like hiding a bottle of gin, but you're not, you're hiding your
patches and tablets. So I think it depends on the individual and
obviously it's going to depend on if people are in recovery… it de-
pends on what levels people are at. Obviously if people are really
unwell, then in the grand scheme of things, it's not the end of the
world, because like you said, life is so diﬃcult, it's so hard, so let me
have that vape or cigarette. Let's be real. But, when things do start to
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improve, with some people with that history of any diﬃculties with
substances, it's going to be quite diﬀerent, the process of trying to
stop.”
(Judith, Community Setting, PWP, Ex-Smoker)
Some MHPs expressed how ECs may prove to be particularly ad-
vantageous by providing a similar experience to smoking for inpatients
that are unable to smoke outside of hospital grounds due to their
conﬁnement on the wards. Others elaborated on ECs' potential in pro-
viding comfort to these patients who smoke partly for the behavioural
rituals:
“What comes to mind is that there are some wards where I know
people can't maybe step out or have leave to smoke… so maybe
having an alternative like an e-cigarette in that situation maybe
something that can help them in that situation.”
(William, Community Setting, PWP, Current Smoker)
A minority of MHPs also proposed that ECs could be a positive al-
ternative for patients who experience anxiety and thus use the rituals of
smoking as a coping mechanism for symptom management. This was
discussed in the context of traditional NRT not being able to provide
these cues:
“So if you think about patients who suﬀer from anxiety, every time
they feel quite anxious they go out for a cigarette. It might be that
actual physical thing of holding the cigarette in their hand and going
outside that the vape would replace, rather than just sitting there
with the patch and feeling quite anxious and not using that beha-
viour.”
(Patricia, Community Setting, Trainee PWP, Non-Smoker)
3.2.2. Sub-theme 2: patient-centred focus
Patient choice was taken into consideration by some MHPs when
determining whether ECs would be a helpful THR product for patients
within their care. One MHP reﬂected on the high smoking prevalence in
this population, which was further used to justify the use of ECs in a
mental healthcare context:
“I think it just needs to be absolutely individualised and led by
patient choice. The patient absolutely needs to be in control of the
plan because they are going to have to live the plan.”
(Sharon, Community Service, Psychiatrist, Ex-Smoker)
[…]
“When you ﬁrst asked the question, I thought wow that's really
stigmatising, why should we treat people with severe mental illness
diﬀerently from people in the general population, why shouldn't we
give them the same care? But I think the key is that prevalence is
diﬀerent, so peer group is diﬀerent, so pressure to smoke is diﬀerent.
So, abstinence might not be a feasible goal, which makes harm re-
duction more, you know…”
(Sharon, Community Service, Psychiatrist, Ex-Smoker)
Even among MHPs who were sceptical of ECs, a minority spoke of
accounts whereby they had encouraged EC use by patients. Although
such accounts were rare and predominantly in the context of inpatient
settings, some MHPs expressed how they would encourage patients who
are already using ECs to take them on escorted leave, in attempt to
dissuade them from purchasing tobacco which would inﬂict ﬁnancial
strain on the patient.
“It's a good way to encourage them as well before we go out on
leave, because it's so expensive so I'm like why don't you just take
your pipe out so you can at least save that £4 and spend it on
shopping instead of spending it on tobacco? It's such a waste of
money now.”
(Charlotte, Inpatient Service, Admin and ward assistant, Non-
Smoker)
Finally, one MHP spoke about how, in spite previously raising
concerns regarding ECs, she allows ECs to be used by patients in their
rooms. Moreover, this MHP elaborated on how, in spite of being ill-
informed regarding ECs, she had read the smoke-free policy and be-
lieved they serve to be a popular alternative source of nicotine for pa-
tients who could not smoke:
“The rule is that they are meant to do it in the bedroom area and we
have to constantly encourage them to do that, because what you
don't want to do is normalize any form of smoking behaviour.”
(Debbie, Inpatient Service, Nurse and Manager, Ex-Smoker)
[…]
“What I felt was I didn't want the patients to suﬀer, I didn't want
them to be unhappy, I felt that saying “you can't smoke and that's it,
I don't want NRT doctor thank you very much”, that it was an al-
ternative to support them. And I still maintain that view… but I do
wonder what is in them [ECs].”
(Debbie, Inpatient Service, Nurse and Manager, Ex-Smoker)
4. Discussion
To our knowledge, this is the ﬁrst study to explore MHPs percep-
tions of THR and ECs, as well as the decision-making processes un-
derlying their use in mental health clinical settings. MHPs adopt a risk-
averse approach when making judgements regarding the safety and
potential eﬀectiveness of ECs in mental healthcare. Speciﬁcally in the
context of the present study, this was predominantly inﬂuenced by a
perceived obscurity surrounding ECs and THR, high prevalence of and
reliance upon unscientiﬁc and misleading information, and perceived
analogies between ECs and conventional cigarettes. Among MHPs who
expressed a degree of endorsement for ECs, this was almost exclusively
on a patient by patient basis rather than expressing general support for
these products. Speciﬁcally, patients' diagnosis and treatment setting
were considered, along with other individual circumstances.
We report elsewhere that MHPs in the current study experience
constraints in their capability, opportunity and motivation to address
smoking with their patients, including having the belief that smoking is
not a priority behaviour to address with mental health patients (Smith
et al., 2019). This is a persistent issue which has not only been found in
mental healthcare, but also among healthcare professionals who work
with other socially disadvantaged groups experiencing high smoking
prevalence, including those in addiction services and the homeless
(Cookson et al., 2014; Garner & Ratschen, 2013). Interestingly, these
socially disadvantaged smokers are often just as motivated to quit
compared to the general population, and interest in EC and experi-
mentation are common among these smokers (Dawkins et al., 2019;
Hefner, Valentine, & Sofuoglu, 2017; Spears et al., 2018). However,
smoking prevalence remains disproportionately higher in these groups,
suggesting that these smokers are lacking the support required to
convert exclusively to ECs. In relation to the present study, MHPs hold
many misconceptions and unfounded concerns regarding ECs which
may be preventing smokers to convert to ECs within these services.
Therefore, it is crucial for research to explore the cause of these con-
cerns, in order to develop interventions to minimise them. One ex-
planation may be that MHPs heavily rely on mental shortcuts when
making decisions regarding ECs, especially in light of resource con-
straints (Smith et al., 2019). For instance, judging ECs based on per-
ceived analogies with conventional cigarettes may be explained by the
cognitive bias known as representative heuristics, and the tendency to
recall information frequently presented by the media over less frequent
training content and scientiﬁc publications may be the consequence of
information and availability bias (Tversky & Kahneman, 1974) (Table 2
presents ﬁnding from theme 1 using a cognitive psychology frame-
work). Indeed, it is widely known that negative press regarding ECs
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tends to be more prevalent in the media compared with positive mes-
sages (McNeill et al., 2018), and so it may not necessarily be of surprise
that such sources are being utilised, particularly among MHPs who feel
they lack resources to address smoking with patients (Smith et al.,
2019).
4.1. Future research
In light of the present ﬁndings, more eﬀorts are needed to improve
the knowledge about ECs among MHPs, in order to guide clinical
practice and decision making with respect to ECs as a THR intervention.
Due to the heterogeneity of the services involved in the present study,
future work should explore attitudes and decision-making regarding
THR and ECs in each area of mental health (i.e. inpatient, community,
primary care, etc.) to generate more in-depth issues that may be unique
to diﬀerent service types. Moreover, future research should expand this
to other settings supporting vulnerable groups presenting with high
smoking prevalence and low cessation rates, including those who pre-
sent with poor MH and coexisting health and social needs (e.g. home-
lessness and substance users).
4.2. Strengths and limitations
The evidence-base around ECs is constantly developing and so the
ﬁndings are limited to the time when they were gathered and analysed.
These qualitative data from a small purposive sample cannot be gen-
eralized to the population of mental health professionals in the UK or
internationally, and so further research is warranted. Focus groups were
used to encourage discussions that were interactive thus generating
further data; however, this means it is not possible to eliminate the
possibility of a ‘bandwagon eﬀect’, whereby participants agree with the
view of others against their own internal beliefs. This may be particu-
larly the case in focus groups where MHPs had diﬀering opinions to
those in positions of authority (i.e. team leaders or managers).
However, the fact that focus groups involved professionals with back-
grounds from a wide variety of disciplines also serves as a strength to
this study by representing views of a multidisciplinary culture which is
often the case in healthcare. This is valuable, as studies in the past have
often solely recruited medical professionals, such as general
practitioners and nurses. Finally, as is true of qualitative research in
general, our account cannot claim to provide a fully objective view,
given intrinsic biases and inﬂuences of the researchers involved in the
analysis. However, we did attempt to triangulate ﬁndings by deviant
case analysis and discussion about and agreement on themes among co-
authors.
5. Conclusion
In summary, our ﬁndings provide insight into how MHPs perceive
THR and ECs, and how they make decisions regarding the implication
of such approaches in mental healthcare. These ﬁndings suggest that
improved dissemination of the evidence-base supporting THR and ECs
as eﬀective tobacco control interventions is warranted. Further ex-
ploration is required in order to determine how the acceptability of
THR and ECs can be improved among MHPs, as this is essential if such
approach is to be successfully integrated across the mental healthcare
pathway as a viable tobacco control approach for smokers with mental
health conditions.
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Table 2
A cognitive psychology framework of the present ﬁndings (with exemplar quotes).
Potential cognitive biases Example quotes Participant characteristics
Ambiguity eﬀect/risk aversion “I think with NRT there is that expectation that you are going to reduce down, so it's clearer. But with
vaping, maybe not so much, and the paraphernalia around it, there is more potential for it to be a lifestyle
rather than a stepping stone toward complete cessation.”
Clinical psychologist, non- smoker
“I wonder how healthier the e-cigs are anyway? I haven't read up too much about them, but they don't
seem that healthier because it has got the chemicals”
Healthcare assistant, social smoker
Representativeness heuristic “I think sometimes if you want a cigarette you kind of want the real thing. I don't know how helpful ECs
would be because it would still be the same rules that you would have to leave and smoke, you couldn't
smoke on the wards, and with e-cigarettes it's the behaviour you have to look at.”
Mental health practitioner, social
smoker
“There is something diﬀerent they put in [ECs] that's bad for you. If you look at it this way, from say
10 years ago, where can you smoke now? Nowhere. So that would make people cut down naturally
because you can't smoke anywhere. But e-cigs you can smoke anywhere.”
Admin and ward assistant, non-
smoker
Focalism “There is a plastic thing, a small one. I don't think I've ever seen someone suck on anything as hard on that
than the patients on the ward when they were given that instead of access to cigarettes. It almost seemed
their nicotine intake was more than if they just had the odd fag during the day because they were
constantly 24 h a day you would see them, then they would go and get a reﬁll. Really sucking really
deeply… I don't know what it does or what's in it, but it just struck me… I couldn't really see what the
point of it was other than stopping them for actually inhaling smoke.”
Clinical psychologist, ex-smoker
“The thing is with smoking it's trying to get them away from their addiction, and that is not getting them
away from their addiction. Even though it's better for their health it's still an addiction. They are still
addicted to something.”
Admin and ward assistant, non-
smoker
Availability heuristic “I can't remember if ECs are covered in the e-learning… I can't remember if I read or heard it, but it was
over the weekend, that young people are taking up vaping rather than smoking, which that's not what its
meant to be… its meant to be an aid to stopping, isn't it.”
Nurse & team leader, social smoker
“I read something in the paper that the percentage of harm they are doing compared to cigarettes is not a
lot of percentage diﬀerence.”
Admin and ward assistant, non-
smoker
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